CareTrust REIT Valuation
Is 7XC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 7XC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 7XC (€29.2) is trading below our estimate of fair value (€50.42)
Significantly Below Fair Value: 7XC is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7XC?
Key metric: As 7XC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 7XC's PE Ratio? | |
|---|---|
| PE Ratio | 58.3x |
| Earnings | US$98.82m |
| Market Cap | US$5.74b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 21.4x |
| Enterprise Value/EBITDA | 25.3x |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does 7XC's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 40.1x | ||
SBRA Sabra Health Care REIT | 44.7x | 18.8% | US$4.4b |
NHI National Health Investors | 27.9x | 10.8% | US$3.5b |
AED Aedifica/SA | 25.1x | 38.3% | €2.7b |
HABA Hamborner REIT | 62.8x | 11.0% | €514.1m |
7XC CareTrust REIT | 58.3x | 45.5% | €5.7b |
Price-To-Earnings vs Peers: 7XC is expensive based on its Price-To-Earnings Ratio (58.3x) compared to the peer average (40.1x).
Price to Earnings Ratio vs Industry
How does 7XC's PE Ratio compare vs other companies in the Global Health Care REITs Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 1 Company | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: 7XC is expensive based on its Price-To-Earnings Ratio (58.3x) compared to the Global Health Care REITs industry average (26.5x).
Price to Earnings Ratio vs Fair Ratio
What is 7XC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 58.3x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 7XC's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €29.20 | €32.02 +9.7% | 8.0% | €35.19 | €25.68 | n/a | 9 |
| Nov ’25 | €29.40 | €30.04 +2.2% | 10.4% | €34.14 | €24.92 | n/a | 9 |
| Oct ’25 | €27.60 | €27.40 -0.7% | 8.4% | €30.72 | €24.39 | n/a | 9 |
| Sep ’25 | €26.80 | €26.58 -0.8% | 7.6% | €29.56 | €24.19 | n/a | 9 |
| Aug ’25 | €24.80 | €25.06 +1.1% | 4.6% | €26.59 | €23.84 | n/a | 9 |
| Jul ’25 | €23.20 | €25.35 +9.3% | 4.2% | €27.01 | €24.21 | n/a | 9 |
| Jun ’25 | €23.40 | €24.42 +4.4% | 6.2% | €26.78 | €21.24 | n/a | 9 |
| May ’25 | €22.80 | €23.73 +4.1% | 5.9% | €25.38 | €21.62 | n/a | 8 |
| Apr ’25 | €22.20 | €23.03 +3.7% | 4.9% | €24.87 | €21.19 | n/a | 8 |
| Mar ’25 | €20.80 | €22.82 +9.7% | 5.4% | €24.98 | €21.28 | n/a | 9 |
| Feb ’25 | €19.00 | €22.73 +19.6% | 4.7% | €24.06 | €21.29 | n/a | 9 |
| Jan ’25 | €20.20 | €22.33 +10.5% | 6.1% | €23.82 | €20.15 | n/a | 8 |
| Dec ’24 | €20.80 | €21.64 +4.1% | 6.8% | €23.67 | €19.12 | n/a | 9 |
| Nov ’24 | €20.40 | €21.87 +7.2% | 4.6% | €22.82 | €19.97 | €29.40 | 9 |
| Oct ’24 | €19.10 | €21.20 +11.0% | 5.7% | €22.51 | €18.76 | €27.60 | 10 |
| Sep ’24 | €18.70 | €20.34 +8.7% | 7.8% | €22.07 | €17.47 | €26.80 | 9 |
| Aug ’24 | €18.50 | €19.73 +6.7% | 7.3% | €21.63 | €17.13 | €24.80 | 9 |
| Jul ’24 | €17.90 | €19.94 +11.4% | 7.5% | €22.01 | €17.42 | €23.20 | 8 |
| Jun ’24 | €17.80 | €19.96 +12.1% | 8.7% | €22.41 | €17.74 | €23.40 | 8 |
| May ’24 | €17.40 | €19.49 +12.0% | 8.7% | €21.88 | €17.32 | €22.80 | 8 |
| Apr ’24 | €17.70 | €19.97 +12.9% | 9.5% | €22.13 | €17.52 | €22.20 | 6 |
| Mar ’24 | €18.00 | €20.12 +11.8% | 8.7% | €22.46 | €17.78 | €20.80 | 8 |
| Feb ’24 | €18.80 | €19.48 +3.6% | 8.5% | €22.15 | €17.54 | €19.00 | 9 |
| Jan ’24 | €17.70 | €19.91 +12.5% | 9.7% | €22.88 | €17.16 | €20.20 | 9 |
| Dec ’23 | €18.50 | €20.16 +9.0% | 9.3% | €23.23 | €17.42 | €20.80 | 9 |
| Nov ’23 | €18.50 | €20.92 +13.1% | 10.0% | €24.30 | €18.22 | €20.40 | 9 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Safestore Holdings
UK£1.6b
Safestore is the UK's largest self storage group with 190 stores on 31 October 2023, comprising 133 wholly owned stores in the UK (including 73 in London and the South East with the remainder in key metropolitan areas such as Manchester, Birmingham, Glasgow, Edinburgh, Liverpool, Sheffield, Leeds, Newcastle, and Bristol), 29 wholly owned stores in the Paris region, 11 stores in Spain, 11 stores in the Netherlands and 6 stores in Belgium.
IHF
UK£9.00
7D
-2.7%
1Y
3.4%
Argan
€1.7b
Engages in designing, building, developing, owning, leasing, and managing logistical platforms in France.
871
€65.60
7D
-0.5%
1Y
-9.6%
Allied Properties Real Estate Investment Trust
CA$2.5b
Allied is a leading owner-operator of distinctive urban workspace in Canada's major cities.
5G8
CA$12.19
7D
-1.2%
1Y
5.2%